ArticleMolecular medicine (Cambridge, Mass.)2025

Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma.

Xing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.